BioSpace News Archive

AgBiome®, a leader in developing innovative products from the Earth’s microbial communities, has announced the submission of Theia™ fungicide, its next product, to the EPA for review.

California’s life science industry provides over 1.4 million jobs in the region, with economic activity generating a total of $372 billion in 2019 alone.

pVerify launches highly scalable, disaster-resistant IT infrastructure for eligibility in collaboration with Onix. “With this enhancement, pVerify joins the ranks of the most robust clearinghouses out there, providing fault tolerance, ability to handle over 100 million transactions a month, and smooth recovery in case of data center outage,” said Robert Dejournett, PhD, Chief Technology Officer, pVerify. “

ValueHealth, LLC, a privately held, nationally trusted digital and surgical healthcare partner announces the opening of Physicians Care Surgery Center, a joint venture partnership with Rothman Orthopaedic Institute, Main Line Health and Jefferson Health and local physicians.

Northeast Scientific Inc., this week announced it has received FDA clearance for reprocessing the .014 Digital IVUS catheter. This is the second 510(k) the Connecticut based company has been awarded for the reprocessing of the IVUS type catheter. While crediting his team in their work addressing the FDA requirements to win the 510(k), CEO Craig Allmendinger went on to say; “By adding the .014 IVUS to our existing portfolio of products, we a

Stellar Health (“Stellar”) and Accurate Diagnostic Laboratories (“Accurate Diagnostic Labs”) are pleased to announce a collaboration to align their efforts around the mission of assisting health care providers to keep patient care and private practice at the absolute forefront of the value-based care (“VBC”) world

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that, pursuant to its existing, exclusive global distribution agreement with Corning Incorporated’s Life Sciences Division for its X-SERIES® product

DispatchHealth, a provider of tech-enabled in-home health care, today announced the closing of $135.8 million growth capital financing. The Series C round was led by Optum Ventures and included participation from existing investors Alta Partners, Questa Capital, Echo Health Ventures, new investors Oak HC/FT, Humana Inc. (NYSE: HUM) and additional strategic investors.

Verde Leaf™ is pleased to announce the appointment of Priscilla Agoncillo to its Board of Directors.

Draper today announced the release of a new scientific article that describes how the company’s technology can be used to test an in vitro human lung model to investigate responses following infection with COVID-19 and influenza.